###begin article-title 0
BP1 is a negative modulator of definitive erythropoiesis
###end article-title 0
###begin p 1
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
###end p 1
###begin p 2
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 138 145 138 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 263 278 <span type="species:ncbi:10090">transgenic mice</span>
###xml 375 380 <span type="species:ncbi:10090">mouse</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 415 420 <span type="species:ncbi:10090">mouse</span>
###xml 521 526 <span type="species:ncbi:10090">mouse</span>
Beta protein 1 (BP1), a human homeotic transcription factor, is expressed during hematopoeisis in the erythroid lineage. To determine the in vivo role of BP1 in erythropoiesis, we have undertaken two complementary approaches using enforced BP1 expression in both transgenic mice and embryonic stem (ES) cells. Despite repeated attempts, only one adult transgenic BP1 founder mouse among 121 mice was obtained. This mouse presumably survived due to transgene mosaicism because the transgene could not be transmitted. This mouse expressed BP1 and displayed splenomegaly, extramedullary erythropoiesis and severe amyloidosis A in the kidney, a phenotype compatible with thalassemia. Consistently, the presence of BP1 transgene in fetuses was associated with paleness and lethality. In ES cells, BP1 expression in primary differentiation appeared to antagonize adult beta-globin expression. In secondary differentiation, BP1 expression reduced significantly beta-globin gene expression in both primitive and definitive erythroid cells, whereas it impaired only the definitive erythroid cell differentiation. These studies showed that BP1 can negatively modulate adult beta-globin gene expression and definitive erythroid cell differentiation, and suggest that BP1 could play a role in thalassemia.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 302 303 302 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 206 211 <span type="species:ncbi:9606">human</span>
The transcription factor beta protein 1 (BP1) is a member of the homeobox gene family and the distal-less subfamily. The expression of BP1 is highly tissue-specific and developmentally restricted. Among 50 human tissues, BP1 was highly expressed in placenta, kidney and at lower levels in fetal liver (1). Such restricted pattern of expression is compatible with a specific gene function in development and/or differentiation.
###end p 5
###begin p 6
###xml 170 171 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 172 173 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 325 326 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 509 510 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 84 89 <span type="species:ncbi:9606">human</span>
###xml 294 300 <span type="species:ncbi:10090">murine</span>
In transient transfection studies, BP1 protein appears to act as a repressor of the human adult beta-globin gene, through two silencers upstream of the beta-globin gene (1-3). In addition, BP1 protein was shown to bind to negative control regions upstream of the adult beta-globin gene and the murine beta-major globin gene (4). The clinical relevance of BP1 is supported by the inverse correlation between the binding affinity of BP1 protein to polymorphic DNA sequences associated with sickle cell disease (5). We found that DNA with stronger BP1 binding in the Indian-Arabo haplotype, or weaker BP1 binding, as in the Bantu haplotype, have respectively, reduced or increased clinical evidence for red blood cell sickling. Taken together, these studies support the hypothesis that BP1 is a physiologic repressor of beta-globin gene expression.
###end p 6
###begin p 7
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 644 645 644 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 584 592 <span type="species:ncbi:9606">patients</span>
###xml 634 642 <span type="species:ncbi:9606">patients</span>
A role for BP1 in bone marrow hematopoiesis is also emerging. BP1 is expressed in purified CD34- hematopoietic bone marrow cells, a primitive subpopulation of human hematopoietic cells, and its expression decreases to undetectable levels during terminal erythropoiesis (1,6). Enforced expression of BP1 in embryonic/fetal erythroid K562 cells leads to decreased erythroid differentiation potential, while ectopic expression of BP1 increases clonogenicity, suggesting a role for BP1 in leukemogenesis. In fact, expression of BP1 was detected in 63% of primary leukemia blasts from AML patients and in 32% of leukemic blasts from T-ALL patients (6).
###end p 7
###begin p 8
###xml 268 269 268 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 369 370 369 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</sup>
###xml 87 102 <span type="species:ncbi:10090">transgenic mice</span>
###xml 440 455 <span type="species:ncbi:10090">transgenic mice</span>
The aim of this study was to determine the role of BP1 in erythroid differentiation of transgenic mice and in totipotent embryonic stem (ES) cells. In ES cells constitutively expressing BP1, we demonstrate marked repression in the generation of definitive erythroid (Ed) cells with no effect on growth of the ES-derived embryoid bodies (EB) or in primitive erythroid (Ep) cells. Moreover, expression of BP1 in definitive erythroid cells in transgenic mice appears incompatible with survival.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Constructs
###end title 10
###begin p 11
###xml 123 124 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 178 179 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 565 566 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 145 150 <span type="species:ncbi:9606">human</span>
###xml 209 214 <span type="species:ncbi:9606">human</span>
###xml 486 501 <span type="species:ncbi:10090">transgenic mice</span>
###xml 526 531 <span type="species:ncbi:10090">mouse</span>
The LCRBP1 construct was produced in p-Bluescript vector by joining the human beta-globin promoter to the 1.1 kb BP1 cDNA (7). Subsequently, the human beta-globin 8 kb midi LCR (8) was linked upstream and the human 2.8 kb beta-globin 3' sequences consisting of 18 bp of exon 2, all of exon 3 and 3' flanking sequences were adjoined downstream. The LCRDeltaBP1 construct was identical to LCRBP1 but without the BP1 cDNA. A 12 kb Sal I-Not I fragment was purified from LCRBP1 to generate transgenic mice in (C57Bl/6J X CBA/J)F2 mouse strains as described previously (8).
###end p 11
###begin title 12
Cell culture and differentiation
###end title 12
###begin p 13
###xml 83 84 83 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 535 537 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
CCE-ES cells (gift from Dr G. Keller, NY) were maintained as described previously (9). ES cells were co-electroporated (10) using equivalent molar ratios of the LCRBP1 or LCRDeltaBP1 and the pSV3neo vector and selected with G418 (400 mug/ml). DNA from several independent subclones was analyzed by Southern blotting with two restriction digests, SalI/EcoRI and SalI/BamHI, and a BP1-beta-globin probe to verify contiguous integrity. Conditions for erythroid differentiation consist of SCF (100 ng/ml), IL-3 (5 ng/ml) and Epo (2 U/ml) (11).
###end p 13
###begin title 14
RNA extraction and expression analysis
###end title 14
###begin p 15
###xml 106 107 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</sup>
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 255 257 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
Total RNA was isolated from ES cells using Trizol reagent (Invitrogen). cDNA synthesis was performed for Ep and Ed samples by two successive series of oligo(dT)-primers and PCR amplification; for EB samples, 1 mug of RNA was used as described previously (12).
###end p 15
###begin p 16
###xml 465 467 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
Semi-quantitative expression analysis for the BP1 transgene and beta-globin genes were carried out with the following primers: for BP1, forward 5'-TGGAGCCTGGTATCAGCATC-3' and reverse 5'-TGGACAGCAAGAAAGCGAGC-3' (in exon 3 beta-globin gene) producing an amplicon of 417 bp; for beta-globin, forward 5'-GGACCCAGCGGTACTTTGATAG-3' (exon 2) and reverse 5'-GTGGCCCAGCACAATCACGAT-3' (in exon 3) generating a 239 bp product. S16 ribosomal primers were described previously (13). Conditions for BP1 amplification were 94degreesC, 30 s, 57degreesC, 30 s, 72degreesC, 30 s for 30 cycles; conditions for beta-globin and S16 were 94degreesC, 30 s, 60degreesC, 30 s, 72degreesC, 30 s for 14 and 20 cycles and a final elongation of 10 min at 72degreesC. Radioactive PCR products were analyzed on 8% polyacrylamide/TBE gel and quantified by phosphoimager. For real-time quantitative analysis, the same primers were used, except the BP1 primers were replaced with forward 5'-CCCCAATTTGTCCTACTCCA-3' and reverse 5'-GGTTGCTGGCAGGACAGGTA-3', and produced an amplicon of 100 bp. Four series of ES primary and secondary differentiation experiments were performed with duplicate of each clone in each experiment. All reactions were performed in triplicate in a master mix (Qiagen, Mississauga, Canada), containing 0.3 muM of each primer. Amplification conditions were 95degreesC, 15 min followed by 44 cycles of 94degreesC, 30 s, 60degreesC, 35 s, 72degreesC, 30 s, in a MX3500pro multiplex quantitative PCR analyzer.
###end p 16
###begin title 17
Histological analysis
###end title 17
###begin p 18
###xml 665 667 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
Age-matched controls and transgenic tissues were formalin-fixed and embedded in paraffin. Tissue sections (5 mum) were stained with hematoxylin/eosin and Congo red for light microsopy. Immunofluorescence for IgG, IgM, IgA, Kappa and Lambda light chains was performed following pronase digestion of paraffin sections. Staining for serum amyloid A (SAA) protein was performed by immunoperoxidase using avidin-biotin labeling. Tissues for ultrastructural analysis were fixed in 2.5% glutaraldehyde-buffered with 0.01 M cacodylate (pH 7.4) and postfixed in 2% osmium tetroxide and embedded in Epon. Ultrathin sections were stained with uranyl acetate and lead citrate (14).
###end p 18
###begin title 19
RESULTS AND DISCUSSION
###end title 19
###begin title 20
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
BP1 expression in vivo appears to be embryonic lethal
###end title 20
###begin p 21
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 257 266 254 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1a</xref>
###xml 370 377 367 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1272 1279 1257 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 241 246 <span type="species:ncbi:9606">human</span>
###xml 303 308 <span type="species:ncbi:10090">mouse</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 400 405 <span type="species:ncbi:10090">mouse</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 831 846 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1550 1556 <span type="species:ncbi:10090">murine</span>
Characterization of the in vivo role of BP1 in erythroid cells was undertaken by introducing a LCRBP1 construct into mice. LCRBP1 was produced by linking the human beta-globin regulatory sequences without the two BP1 silencer regions to the human BP1 cDNA (Figure 1a). Only one adult founder transgenic mouse with an intact transgene was generated from 121 mice (P28 in Table 1). This female founder mouse appeared to have one copy of the transgene and was extensively mated with wild-type (C57Bl/6J X CBA/J)F1 mice. From 11 litters, all 76 mice were negative for the transgene. The average litter size was 7 pups, well below the 10-12 pups on average for these strains. The lack of transmission can be explained by high mosaicism and/or embryonic lethality resulting from BP1 transgene expression. The very low frequency of adult transgenic mice obtained compared to the frequency of approximately10-15% for other transgenes (data not shown), also indicated that the expression of BP1 in differentiating and mature erythroid cells could be lethal during gestation. To test this hypothesis, microinjection of additional oocytes of the LCRBP1 construct was carried out and fetuses were analyzed for the presence of the transgene at various stages of gestation. As shown in Table 1, one of two embryos at E15.5 and four of 27 embryos at E16.5 were LCRBP1 positive. Among those four transgenic fetuses, one was resorbed and one was pale (anemic). The frequency of transgenic fetuses decreased thereafter. Since the maximal expression of the endogeneous murine adult globin gene occurs at E16.5 for definitive erythroid cells, it would be expected that repression by BP1 would be most detrimental from this stage onwards.
###end p 21
###begin p 22
###xml 114 123 114 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1b</xref>
###xml 423 424 411 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 461 462 449 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 478 479 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 640 642 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 972 987 940 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2a and b</xref>
###xml 1074 1089 1042 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2c and d</xref>
###xml 1273 1288 1241 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2c and d</xref>
###xml 1397 1412 1365 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2e and f</xref>
###xml 1510 1512 1478 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 220 225 <span type="species:ncbi:10090">mouse</span>
###xml 312 317 <span type="species:ncbi:10090">mouse</span>
###xml 408 413 <span type="species:ncbi:10090">mouse</span>
###xml 605 609 <span type="species:ncbi:10090">mice</span>
###xml 1688 1693 <span type="species:ncbi:10090">mouse</span>
The only adult female transgenic founder expressed BP1 in peripheral blood, shown by RT-PCR and Rnase protection (Figure 1b and data not shown). Pathological analysis upon the unexpected death of this transgenic founder mouse showed splenic enlargement by approximately2-fold compared to the age-matched control mouse strain. The bone marrow cellularity was increased by 1.8-fold in the femur of the founder mouse (8.4 x 107cells) relative to controls (4.6 x 107 +/- 0.9 cells; n = 4) which is consistent with the approximately1.4-fold increase in cellularity observed in hemizygous beta-globin knock-out mice, a model of beta-thalassemia (15). Both these features are indicative of stimulated hematopoiesis and consistent with the observation of numerous foci of extramedullary hematopoiesis in organs such as spleen and kidney. While renal tissues had normal tubules, interstitium and blood vessels, the glomeruli showed expansion of the mesangium compared to controls (Figure 2a and b), with narrowing of the capillaries due to large Congo red positive amyloid deposits (Figure 2c and d). By specific staining for identification of amyloid precursor proteins, these amyloid deposits were negative for immunoglobulins, kappa and lambda light chains but positive for SAA (Figure 2c and d). Electron microscopy revealed glomerular deposits of randomly oriented 8-10 nm fibrils typical of amyloid (Figure 2e and f). Presence of increased SAA is observed in conditions of chronic inflammation as in thalassemia (16). The composite of these pathologic findings, increase in erythropoiesis/hematopoiesis and amyloid deposits, are consistent with a thalassemic condition in the BP1 transgenic mouse.
###end p 22
###begin title 23
BP1 expression impairs definitive erythropoiesis
###end title 23
###begin p 24
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 368 376 364 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
To gain further insight into the in vivo role of BP1 in primitive and definitive hematopoiesis, the LCRBP1 and empty vector control LCRDeltaBP1 constructs were targeted to totipotent ES cells by co-electroporation with the pSV3neo vector. Several independent clones were obtained for both constructs and were analyzed by Southern blot for integrity of the transgenes (Figure 3). Among the clones with an intact transgene, three clones for LCRBP1 (1, 2 and 5 transgene copies) and three clones for LCRDeltaBP1 (1 and 2 copies) were selected for subsequent analysis.
###end p 24
###begin p 25
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 750 757 738 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 865 874 853 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4a</xref>
###xml 1001 1010 986 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4b</xref>
###xml 1122 1130 1103 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 1703 1710 1663 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 1715 1723 1675 1683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 1965 1966 1919 1920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 1804 1810 <span type="species:ncbi:10090">murine</span>
###xml 1930 1935 <span type="species:ncbi:9606">human</span>
Parental and electroporated ES cells were differentiated in vitro to form EBs (which contain a variety of cell types) and assessed for BP1 expression. The potential of these electroporated ES cells to generate EBs was not significantly affected, as the primary plating efficiency was 17.5 +/- 3.9% for parental ES cells, 17.1 +/- 4.3% for LCRDeltaBP1 cells and 14.1 +/- 3.5% for LCRBP1 cells (mean +/- SD). In addition, LCRBP1 electroporated ES cells yielded similar-sized EBs as the parental and empty vector ES cells (data not shown), suggesting that the number of cells per EB was not altered. During this primary differentiation process, the percentage of hemoglobinized EBs was comparable between the parental and electroporated cells at day 9 (Table 2). To quantify expression levels, we first established the RT-PCR conditions to be within the linear range (Figure 4a). The expression time course of the endogenous adult beta-globin gene was similar between wild-type and empty vector control (Figure 4b and data not shown). Noticeably, wild-type ES cells or EBs with empty LCRDeltaBP1 control did not express BP1 (Figure 4). In two independent experiments, the expression of BP1 in the LCRBP1 clones was highest at days 6 and 9 and decreased from day 12 onwards whereas the beta-globin gene showed strongest expression on days 12 and 15. Semi-quantitative analysis of the LCRBP1 clones indicated a approximately1.5- to 2-fold reduction in beta-globin expression normalized to S16 on days 12 and 15 relative to empty vector control. Consistently, quantification by real-time PCR of EBs at day 9 showed a decrease in beta-globin expression levels by at least 4-fold, a time when BP1 is strongest (Table 3 and Figure 4). Hence the LCRBP1 clones indicated that BP1 might antagonize expression of the murine beta-globin gene. Conversely, repression of BP1 in the erythroleukemic K562 cell line was shown to enhance endogeneous human beta-globin gene expression (3).
###end p 25
###begin p 26
###xml 238 239 238 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</sup>
###xml 359 366 355 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 424 425 420 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</sup>
###xml 562 569 546 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 584 591 568 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 768 769 752 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 970 971 954 955 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 1076 1077 1060 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</sup>
###xml 1115 1122 1099 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 1381 1382 1362 1363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</sup>
###xml 1388 1389 1369 1370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 1469 1476 1450 1457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 1762 1763 1737 1738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 1912 1913 1887 1888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 2420 2422 2380 2382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 2423 2425 2383 2385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 2597 2598 2557 2558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 2202 2207 <span type="species:ncbi:10090">mouse</span>
###xml 2252 2256 <span type="species:ncbi:10090">mice</span>
To investigate more precisely the role of BP1, we carried out secondary differentiation under conditions favorable for erythroid/hematopoietic colony forming cells (CFCs). In four series of experiments, the number of primitive erythroid Ep progenitors detected at day 3 was unchanged upon differentiation of parental, LCRBP1 and control LCRDeltaBP1 ES cells (Table 2). Quantitative expression analysis from pools of LCRBP1 Ep normalized to S16 showed a significant increase in BP1 expression levels (approximately20- to 25-fold) compared to pools of LCRBP1 EBs (Table 3). As shown in Table 2, this increase in BP1 expression appeared to exert no significant negative effect on production of primitive erythroid cells. However, the number of definitive erythroid-CFC (Ed-CFC) at day 7, as identified by hemoglobinized colonies, was significantly decreased in LCRBP1 relative to empty vector and parental ES cells. Pools of individual hemoglobinized definitive erythroid Ed LCRBP1 progenitors showed high BP1 expression levels similar to those observed for primitive erythroid Ep LCRBP1 progenitors by real-time PCR (Table 3). These results indicated that the elevated BP1 expression led to a specific decrease of definitive erythropoiesis compared to primitive erythropoiesis. Importantly, BP1 expression caused a significant decrease in adult beta-globin gene expression for both Ep and Ed cells relative to wild-type and empty vector control, reaching 2- to 2.5-fold (Table 3). In contrast to definitive erythropoiesis, the adult beta-globin chain is not the most prevalent beta-like globin chain in primitive erythropoiesis and consistently, decreased expression had no apparent impact on primitive differentiation. Of note, pools of hemoglobinized erythroid Ed LCRBP1 progenitors were picked for expression analysis since non-hemoglobinized colonies include other cell types. However, pooling hemoglobinized Ed would be expected to select for higher beta-globin levels, possibly skewing the data toward less repression. Thus, the actual decrease in beta-globin may be much greater than the one observed. Nevertheless, such a decrease in expression would be likely to have an important impact in the mouse, since the hemizygous beta-globin knock-out mice with only a 25% reduction in beta-globin gene expression resulted in a severe beta-thalassemic phenotype with half the levels of hemoglobin and hematocrit levels (15,17). Further, expression of BP1 did not significantly alter the number of mac-CFC (macrophages), mix-CFC (mixed lineages: erythroid/granulocyte/macrophage/megakaryocyte) or Ed/mac-CFC (data not shown). Therefore, BP1 expression in the erythroid lineage targeted specifically definitive erythroid progenitors.
###end p 26
###begin p 27
###xml 193 201 190 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 466 471 <span type="species:ncbi:9606">human</span>
In summary, our findings demonstrate that high expression of BP1 leads to decreased adult beta-globin gene expression and inhibition of definitive erythroid differentiation. Together, previous in vitro studies and the data presented here support the concept that sustained BP1 expression, through repression of the adult beta-globin gene, may cause globin chain imbalance resulting in thalassemia. Future studies should be directed to determining the role of BP1 in human thalassemia.
###end p 27
###begin p 28
This study was supported by the CIHR/IRSC of Canada to M.T. including Open Access publication charges.
###end p 28
###begin p 29
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement.</italic>
Conflict of interest statement. None declared.
###end p 29
###begin title 30
REFERENCES
###end title 30
###begin article-title 31
BP1, a homeodomain-containing Isoform of DLX4, represses the beta-globin gene
###end article-title 31
###begin article-title 32
Identification of upstream regulatory elements that repress expression of adult beta-like globin genes in a primitive erythroid environment
###end article-title 32
###begin article-title 33
###xml 114 119 <span type="species:ncbi:9606">human</span>
Inhibition of beta protein 1 expression enhances beta-globin promoter activity and beta-globin mRNA levels in the human erythroleukemia (K562) cell line
###end article-title 33
###begin article-title 34
###xml 50 55 <span type="species:ncbi:9606">human</span>
A common protein binds to two silencers 5' to the human beta-globin gene
###end article-title 34
###begin article-title 35
###xml 132 133 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sup>
DNA sequence variation in a negative control region 5' to the beta-globin gene correlates with the phenotypic expression of the betas mutation
###end article-title 35
###begin article-title 36
BP1, a new homeobox gene, is frequently expressed in acute leukemias
###end article-title 36
###begin article-title 37
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BP1</italic>
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLX7</italic>
Distinct functions of two isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the beta-globin gene
###end article-title 37
###begin article-title 38
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD
###end article-title 38
###begin article-title 39
Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture
###end article-title 39
###begin article-title 40
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Rescue of erythroid development in gene targeted GATA-1- mouse embryonic stem cells
###end article-title 40
###begin article-title 41
Hematopoietic commitment during embryonic stem cell differentiation in culture
###end article-title 41
###begin article-title 42
###xml 63 68 <span type="species:ncbi:9606">human</span>
Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD)
###end article-title 42
###begin article-title 43
C-MYC-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent
###end article-title 43
###begin article-title 44
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Sickle cell disease of transgenic SAD mice
###end article-title 44
###begin article-title 45
###xml 120 124 <span type="species:ncbi:10090">mice</span>
Differential regulatory and compensatory responses in hematopoiesis/erythropoiesis in alpha- and beta-globin hemizygous mice
###end article-title 45
###begin article-title 46
Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia
###end article-title 46
###begin article-title 47
###xml 25 26 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 75 78 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">maj</sup>
###xml 83 86 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">min</sup>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Mouse model of human beta0 thalassemia: Targeted deletion of the mouse betamaj-betamin-globin genes in embryonic stem cells
###end article-title 47
###begin article-title 48
###xml 66 71 <span type="species:ncbi:9606">human</span>
A 3' enhancer contributes to the stage-specific expression of the human beta-globin gene
###end article-title 48
###begin title 49
Figures and Tables
###end title 49
###begin p 50
###xml 64 65 64 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 566 568 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 722 723 710 711 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 817 818 805 806 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 271 276 <span type="species:ncbi:9606">human</span>
###xml 638 643 <span type="species:ncbi:10090">mouse</span>
###xml 836 841 <span type="species:ncbi:10090">mouse</span>
###xml 873 878 <span type="species:ncbi:10090">mouse</span>
###xml 934 939 <span type="species:ncbi:9606">Human</span>
###xml 1017 1022 <span type="species:ncbi:10090">mouse</span>
###xml 1078 1083 <span type="species:ncbi:10090">mouse</span>
LCRBP1 transgene structure and expression in transgenic mouse. (a) The LCRBP1 construct was produced in a bluescript vector by joining the human beta-globin promoter (pr) lacking the two silencer sequences (-264/SnaB1 to +48/NcoI) to the 1.1 kb BP1 cDNA (SmaI-XbaI). The human beta-globin 8 kb midi LCR was linked to this DNA upstream, and downstream 2.8 kb of the beta-globin gene including 3' sequences of exon 2, all of exon 3, and 3' flanking sequences [BamHI (nt 62613) to XbaI (nt 65421), GenBank accession no. U01317), containing the two globin 3' enhancers (18). The probe BP1-beta-globin (SnaBI-XbaI, 3.2 kb) used for transgenic mouse screening by Southern blot analysis is indicated above the LCRBP1 construct. (b) Expression analysis in peripheral blood using RT-PCR. Three RNA blood samples from control H2O (C), transgenic mouse (tg BP1) and control identical mouse strain (WT) were monitored for BP1 and S16 expression. Human BP1 expression was readily detectable in the blood of the transgenic founder mouse and undetectable in the blood of the control identical mouse strain. Expression of the ribosomal protein S16 served as internal control.
###end p 50
###begin p 51
###xml 68 69 68 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 333 334 333 334 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 876 877 876 877 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 1098 1099 1098 1099 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</bold>
###xml 1248 1249 1248 1249 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</bold>
###xml 1399 1400 1399 1400 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</bold>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
###xml 377 382 <span type="species:ncbi:10090">mouse</span>
###xml 666 671 <span type="species:ncbi:10090">mouse</span>
###xml 911 916 <span type="species:ncbi:10090">mouse</span>
###xml 956 961 <span type="species:ncbi:3750">apple</span>
###xml 1133 1138 <span type="species:ncbi:10090">mouse</span>
###xml 1466 1471 <span type="species:ncbi:10090">mouse</span>
Histopathological analysis of the LCRBP1 transgenic founder mouse. (a) Normal histology of the kidney displaying small regular glomeruli and surrounding tubulo-interstitial compartment (H&E, x100). Inset shows glomerulus of normal size and cellularity with patent capillaries and basement membranes of normal thickness (H&E, x400). (b) Renal histology of the transgenic LCRBP1 mouse showed diffuse and uniform enlargement of the glomeruli due to expansion of the glomerular tuft by amorphous pale eosinophilic material. The outlying tubules, interstitium and blood vessels are uninvolved (H&E, x100). Inset shows a representative glomerulus of the transgenic LCRBP1 mouse with expansion of the mesangium and narrowing of the glomerular capillary lumina by voluminous deposits of amorphous material typical of amyloid. The glomerular cellularity appeared reduced (H&E, x400). (c) Kidney of the transgenic LCRBP1 mouse viewed under polarized light displayed apple green birefringence diagnostic of amyloid deposits in a diffuse and global glomerular distribution (Congo red, polarized light, x100). (d) Kidney of the transgenic LCRBP1 mouse showed strong diffuse and global glomerular positivity for serum amyloid A protein (SAA immunostain, x250). (e) Ultrastructural analysis of a normal renal glomerular capillary showed the normal glomerular architecture, without fibrillar deposits (EM, x6000). (f) Ultrastructure of a renal glomerulus from the transgenic LCRBP1 mouse showed abundant randomly oriented 8-10 nm fibrils expanding the mesangial regions and narrowing the adjacent glomerular capillary lumen (EM, x6000). Inset shows fibrils at higher magnitude (EM, x20 000).
###end p 51
###begin p 52
###xml 257 266 249 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1a</xref>
Integrity of the BP1 transgene in ES cells. Southern blot analysis of electroporated ES cells with LCRDeltaBP1 and LCRBP1 constructs. Restriction enzyme digestion was carried out for LCRDeltaBP1 and LCRBP1 clones using SalI/BamHI. Probe used is depicted in Figure 1a and spanned the adult beta-globin and BP1 sequences. Expected fragments are 6.1 and 2.8 kb for the LCRDeltaBP1clones, and 7.2 and 2.8 kb for the LCRBP1 clones. The intensity of the 6.1 kb band of LCRDeltaBP1 clones is weaker than the 2.8 kb or the 7.2 kb of the LCRBP1 clones since only approximately0.3 kb of the probe is homologous to globin. Extra bands correspond to junction of the constructs with genomic sequences. M, molecular weight marker lambda digested with HindIII and C, copy of LCRBP1 unit length.
###end p 52
###begin p 53
###xml 103 104 100 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 489 490 483 484 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 1049 1051 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
Expression analysis of BP1 and beta-globin genes in EBs at various stages of primary differentiation. (a) Demonstration of linearity of RT-PCR amplification. Varying quantities of total cDNA aliquots were amplified with primers specific for BP1, beta-globin and S16 as internal control to ensure that conditions were within linear range of amplification. The reactions were evaluated semiquantitatively on polyacrylamide gels scanned by phosphoimager and values plotted on linear graphs. (b) Parental ES cells (WT), ES cells containing the empty vector (LCRDeltaBP1) or ES cells containing BP1 (LCRBP1) were differentiated into embryoid bodies (EBs). Expression analysis of BP1 and of the endogeneous beta-globin gene was carried out by RT-PCR on the indicated days of differentiation, using S16 expression as an internal control. Days indicated were selected for analysis of the kinetics of erythroid differentiation since primitive erythroid expression is maximum on day 7 and definitive erythroid lineage expression is high from day 5 to day 12 (11). Semi-quantitative evaluation was carried out for each sample run on the same gel and normalized to the ribosomal RNA control.
###end p 53
###begin p 54
Genotype analysis of fetuses/pups from LCRBP1 microinjected oocytes
###end p 54
###begin p 55
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aAmong 4 fetuses: 1 resorbed and 1 pale.
###end p 55
###begin p 56
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
bFetus completely resorbed.
###end p 56
###begin p 57
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
cMouse does not transmit the transgene.
###end p 57
###begin p 58
Quantification of erythroid progenitors
###end p 58
###begin p 59
###xml 99 100 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</sup>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 330 331 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</sup>
###xml 338 339 338 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</sup>
###xml 346 347 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 360 361 360 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 366 367 366 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 523 524 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 542 543 536 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Analysis was carried out on optimal culture days for EBs (day 9), primitive erythroid progenitors Ep(day 3), definitive erythroid progenitors Ed (day 7) from parental or electroporated ES cells as described (9). The proportion of erythroid CFC was determined in the presence of BP1 expression for EBs (% hemoglobinized Hb/ EBs), Ep (No. Ep per 105 cells) and Ed (% Ed/total colonies). The data from wild type WT, LCRDeltaBP1 (mean of two clones), or LCRBP1 from three clones (1-3) are shown as mean +/- standard deviation. P-value: student's t-test.
###end p 59
###begin p 60
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 32 33 32 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 44 46 42 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">**</sup>
###xml 46 47 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 79 82 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">***</sup>
###xml 82 83 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Values are compared to WT-CCE: *P </= 0.01, **P </= 0.001, and to LCRDeltaBP1: ***P </= 0.01.
###end p 60
###begin p 61
Quantitative expression of BP1 and adult beta-globin genes in erythroid progenitors
###end p 61
###begin p 62
The data from wild type (WT), LCRDeltaBP1 (mean of three clones), or LCRBP1 from three clones (1 to 3) are shown. Values of real-time PCR represent relative units normalized to control S16 expression +/- standard deviation. N.D.: Not detected.
###end p 62
###begin p 63
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 27 32 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P &#8804;</italic>
###xml 39 41 37 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">**</sup>
###xml 41 42 39 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Statistical significance: *P </= 0.05, **P </= 0.005, compared to WT.
###end p 63

